|
|
|
Volumn 9, Issue 5, 2002, Pages
|
|
Optimising management of patients with hypertension and diabetes
|
|
Author keywords
Angiotensin II receptor antagonists; Blood pressure; Diabetes; Guidelines; Hypertension; Renal failure
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
GLUCOSE;
IRBESARTAN;
LOSARTAN;
PLACEBO;
VASODILATOR AGENT;
BLOOD GLUCOSE MONITORING;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COUGHING;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DIALYSIS;
DISEASE ASSOCIATION;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
EVIDENCE BASED MEDICINE;
FLUSHING;
GENERAL PRACTITIONER;
HEALTH CARE DELIVERY;
HEALTH CARE QUALITY;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
IMPOTENCE;
KIDNEY DISEASE;
KIDNEY FAILURE;
KIDNEY FUNCTION;
LIFESTYLE;
MICROALBUMINURIA;
MORBIDITY;
MORTALITY;
NATIONAL HEALTH SERVICE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT CARE;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PREVALENCE;
PRIMARY MEDICAL CARE;
PROTECTION;
QUALITY OF LIFE;
REVIEW;
RISK ASSESSMENT;
SIDE EFFECT;
STROKE;
TREATMENT FAILURE;
|
|
EID: 0036572285
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (12)
|
